investor losses

Class action securities fraud lawsuits filed against Klarna, Agilon Health, and Fermi. Investor lead plaintiff deadlines range from February 20 to March 6, 2026.

Class action filed against Ramaco Resources (METC) alleging misrepresentations about Brook Mine operations. Stock fell 9.6%; investors from July-October 2025 eligible to join lawsuit.

Portnoy Law Firm filed securities class action against Ultragenyx Pharmaceutical, alleging the company made false statements about investigational drug setrusumab and concealed material clinical trial risks.

Class action lawsuit filed against Klarna for allegedly making false statements about risks associated with loan losses in its September 2025 IPO.

Ultragenyx faces securities lawsuit alleging false claims about drug setrusumab for bone disease. Investors have until April 6, 2026 deadline to join class action.

Rosen Law Firm investigates Nidec for accounting fraud allegations in China operations. Stock fell 22.7% after company disclosed accounting irregularities to investors.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and supplier risks. March 13, 2026 deadline set for investors to claim lead plaintiff status.

Pomerantz launches class action against Vistagen after failed clinical trial caused 80% stock drop. March 16, 2026 deadline for investors to join lawsuit.

Class action lawsuit filed against China Liberal Education for alleged securities fraud involving fraudulent social media advisors that artificially inflated stock prices before collapse.

Law firm Block & Leviton investigates GEMI for potential securities violations after three senior executives departed amid 10% stock decline and 25% workforce reduction.

Portnoy Law Firm files class action against Oracle for failing to timely disclose a $15 billion CapEx increase tied to its OpenAI partnership deal.

Law firm sues Quantum Biopharma for alleged market manipulation through spoofed sell orders, claiming defendants artificially suppressed stock price from 2021-2025.

Pomerantz Law Firm files class action against Quantum Biopharma, alleging Canadian banks used spoofed orders to artificially depress stock price and buy shares at reduced rates.

Schall Law Firm files securities fraud class action against Picard Medical for allegedly misleading investors through false statements and an alleged "pump and dump" scheme during September-October 2025.

Varonis Systems class action suit has March 9, 2026 deadline for investors seeking lead plaintiff status over alleged false statements.

Ardent Health faces securities class action for allegedly inflating receivables through misleading accounting practices. Class period runs July 2024 through November 2025.

KDDI faces securities investigation over delayed earnings disclosure and potential misleading business information. Stock fell 11.4% as Rosen Law Firm explores class action litigation for shareholders.

Nidec's stock plunges 22.7% after announcing accounting irregularities at its China unit. Class action litigation launched investigating potential securities law violations and shareholder damages.

Agilon Health faces securities class action lawsuit alleging materially false 2026 financial guidance and misleading statements about risk mitigation. Investors from February-August 2025 may participate.

F5 faces class action lawsuit over undisclosed BIG-IP security breach. Stock plunged 10.9% after October disclosure; shareholders sought for litigation by February 17 deadline.